A survey of the kinome pharmacopeia reveals multiple scaffolds and targets for the development of novel anthelmintics
Abstract Over one billion people are currently infected with a parasitic nematode. Symptoms can include anemia, malnutrition, developmental delay, and in severe cases, death. Resistance is emerging to the anthelmintics currently used to treat nematode infection, prompting the need to develop new ant...
Saved in:
Main Authors: | Jessica Knox, Nicolas Joly, Edmond M. Linossi, José A. Carmona-Negrón, Natalia Jura, Lionel Pintard, William Zuercher, Peter J. Roy |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d0e282a9e8e24d77b3d9aefd33a45006 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacopeia and Anvisa: a necessary symbiosis
by: Luís Mauricio T. R. Lima
Published: (2019) -
Rainforest pharmacopeia in Madagascar provides high value for current local and prospective global uses.
by: Christopher D Golden, et al.
Published: (2012) -
Anthelmintic resistance and homeostatic plasticity (Brugia malayi)
by: Sudhanva S. Kashyap, et al.
Published: (2021) -
Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses
by: Ghazanfar Abbas, et al.
Published: (2021) -
Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types
by: Runjun D. Kumar, et al.
Published: (2017)